The 2017 ISPE Aseptic Conference will take place 7 – 8 March in Reston, Virginia. As Co-Chair of the program committee, I am beyond excited to kick off the event and watch attendees explore the ideals behind this year’s theme:
While there are many reasons why you should attend the 2017 ISPE Aseptic Conference, I’ve narrowed it down to three. First, the event will feature an impressive line-up of concurrent sessions for aseptic and barrier technology.
Secondly, this two-day event includes a solution-filled exhibit hall that will provide the opportunity to learn about technological innovations currently trending in the aseptic sector. Exhibitors will have information on testing equipment and methods, process controls, filtration, and many of the applications used in aseptic processing and RABS. Third, the Interactive Regulatory Panel Session will allow you to get your most challenging questions answered, and hear regulators' questions for the audience. This session will use an interactive app to solicit questions from the audience, so bring your smart phones! And last but not the least, the ever popular Industry Panel will feature, the latest in clean room technologies, and will present advantages and disadvantages of eBeam, Slitter, NO2-Decontamination, Autoclave, Syringe tub introduction and technologies for disposables in “How to Reach the Point of Fill - Introduction Techniques into the Aseptic Core Area”. Additionally, you can expect to walk away with an array of key takeaways... Learn how to:
Visit the 2017 Aseptic Processing Conference website at for more information and to register. I look forward to seeing you in March!
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...